NCT03021369

Brief Summary

The digital pleural drainage system Topaz+ by Medela is compared to the analogue system Atrium OCEAN by Maquet in patients undergoing cardiac surgery. The study is prospectively randomized with an all-comer setup. The patients are randomly selected for one of the systems. The surgery is performed in the standard fashion and chest tubes are placed routinely by the surgeon depending on the type of surgery. A retrosternal 32 French drain is placed in every patient and pericardial and/or pleural drains are optional. The postoperative course does not vary from the clinical standard and the chest tubes are removed according to institutional standard. The clinical data about fluid amount, time of removal, air leaks, tamponade are routinely collected in a digital patient documentation system.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
374

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2016

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 8, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 13, 2017

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2018

Completed
Last Updated

February 25, 2020

Status Verified

February 1, 2020

Enrollment Period

1.2 years

First QC Date

January 8, 2017

Last Update Submit

February 22, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Detection of air leak due to lung leakage or injury during surgery by the pleural drainage system.

    The Thopaz+ system displays the amount of air leak on the screen in ml/min and the Ocean system is a 'wet seal' system, where bubbles in the box might indicate an air leak. If air leak is detected, the train cannot be removed and has to stay until no more air leak is detected. If air leak is unclear, chest x-rays with clamped drains are performed. If an pneumothorax is visible in the x-ray, the drains have to stay, otherwise they can be removed safely. The digital air leak detection and quantification by the Thopaz+ system might help in clearly detecting the air leaks.

    Occurrence of air leak is until the drain is removed (usually postoperative day 2 or 3)

Secondary Outcomes (4)

  • Time of chest drain removal

    Number of days until the chest drains are removed (usually postoperative day 2 or 3, depending on air leak and amount of fluid).

  • Fluid amount

    Total amount of fluid at the time of chest drain removal (usually postoperative day 2 or 3, depending on air leak and amount of fluid).

  • Number of patients with pericardial tamponade that has to be treated by puncture or surgically

    Occurrence through hospital stay (an average of 1 week).

  • Number of patients with pleural effusion at discharge echo, without intervention

    Occurrence through hospital stay (an average of 1 week).

Study Arms (2)

Pleural drainage system Medela

ACTIVE COMPARATOR

These patients receive the digital Medela system

Device: Pleural drainage system

Pleural drainage system Ocean

ACTIVE COMPARATOR

These patients receive the analogue Maquet system

Device: Pleural drainage system

Interventions

Pleural drainage system is connected to the chest tubes after surgery.

Pleural drainage system MedelaPleural drainage system Ocean

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adult patients undergoing cardiac surgery
  • capability to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kerckhoff Klinik

Bad Nauheim, 61231, Germany

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 8, 2017

First Posted

January 13, 2017

Study Start

September 1, 2016

Primary Completion

December 1, 2017

Study Completion

March 1, 2018

Last Updated

February 25, 2020

Record last verified: 2020-02

Locations